Added to YB: 2024-01-19
Pitch date: 2024-01-19
NVTS [bullish]
Novartis India Limited
-7.5%
current return
Author Info
Company Info
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.
Market Cap
INR 20.0B
Pitch Price
INR 865.45
Price Target
16.70 (-98%)
Dividend
3.09%
EV/EBITDA
14.50
P/E
18.74
EV/Sales
3.90
Sector
Pharmaceuticals
Category
growth
Navitas, outlook post investor day
$NVTS: GaN innovator expanding in power mgmt chips. $1.25B pipeline adds EV, solar, data center to mobile fast chargers. 15% share of $4B '26 GaN mkt at 6.5x sales = 36% IRR. Price tgt $16.7. Risks: competition, gross margins <50%, reliance on China gallium supply.
Read full article (16 min)